Roy Herbst, MD, PhD

In this video, Roy Herbst, MD, PhD, spoke with Healio about the practice changing IMpower010 trial presented at the virtual ASCO Annual Meeting.

Roy Herbst, MD, PhD, discussed updated toxicity data from the Lung-MAP non-matched sub-study S1800A presented at the virtual ASCO Annual Meeting.

With multiple approvals and more treatments in the pipeline, there have been “amazing” advances in lung cancer treatment over the past year, Roy Herbst, MD, PhD, told Healio.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, spoke with Healio about presentations from the Chemotherapy Foundation Symposium exploring liquid biopsy in lung cancer.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, provided a quick rundown of presentations from the Chemotherapy Foundation Symposium that focused on targeted therapy.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, highlighted updated data in squamous cell lung cancer and mesothelioma presented at the Chemotherapy Foundation Symposium.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, discussed this year’s Chemotherapy Foundation Symposium.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, described findings from the PIONeer study, which was developed through a public-private partnership in France.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, explained findings from the phase 3 trial, EMPOWER-Lung 1.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, highlighted Keynote 24, which was presented at ESMO Virtual Congress 2020.